| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0065 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |